KOREA PHARMA Co., Ltd. announced a private placement of series 3 bearer type no interest no guarantee private placement convertible bonds for an aggregate gross proceeds of KRW 50,000,000,000 on October 22, 2021. The transaction is expected to close on October 26, 2021. The transaction has been approved by the board of directors of the company.